» Articles » PMID: 9332318

Protein C and Protein S in Homozygous Sickle Cell Disease: Does Hepatic Dysfunction Contribute to Low Levels?

Overview
Journal Br J Haematol
Specialty Hematology
Date 1997 Oct 23
PMID 9332318
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to confirm reports of low protein C (PC) and S (PS) concentrations in steady-state patients with homozygous sickle cell (SS) disease when compared to a racially matched normal haemoglobin (AA) control group and to examine the mechanisms of this reduction with respect to hepatic function, coagulation activation and haematological indices. In 36 SS patients and 35 AA race-matched controls PC (functional and immunoreactive), PS (free and total) were measured. C4B binding protein (C4B) was assessed by immunoelectrophoresis and D-dimer by ELISA. Hepatic function was assessed by prothrombin (PT) time (49 SS, 64 AA), factor V (34 SS, 36 AA) and factor VII concentrations (28 SS, 29 AA). Proteins induced in vitamin K absence or antagonism (PIVKA) were sought in 12 SS's. The relationship between PC, PS and total bilirubin, haemoglobin (Hb) F and reticulocyte count was also assessed. PC, PS and C4B were lower in SS disease. SS patients had longer PT times, and lower factor V and VII concentrations in comparison to AA controls. PC (functional and immuno-reactive) and free PS correlated with PT. Within SS genotype PT correlated negatively with factor V and factor VII. Factor V and VII were positively correlated. PIVKAs were not detected. There was no correlation between PC, PS and D-dimer, haemolytic rate or Hb F concentration. Prolongation of PT time, low factor V and VII suggest that hepatic dysfunction, rather than coagulation activation or haemolytic rate, accounts for the reduced concentrations of PC and PS in steady-state SS disease. The absence of PIVKAs suggests a hepatocellular problem.

Citing Articles

Routine hemostasis profile in steady state sickle cell disease adult patients compared to laboratory values, between phenotypes and during pregnancy: A retrospective, descriptive study.

Affo C, Schmidt C, Bosquet A, Dumont B, Mahe I EJHaem. 2024; 5(5):920-928.

PMID: 39415924 PMC: 11474294. DOI: 10.1002/jha2.876.


The APC-EPCR-PAR1 axis in sickle cell disease.

Ramadas N, Sparkenbaugh E Front Med (Lausanne). 2023; 10:1141020.

PMID: 37497271 PMC: 10366386. DOI: 10.3389/fmed.2023.1141020.


Sickle Hepatopathy.

Praharaj D, Anand A J Clin Exp Hepatol. 2021; 11(1):82-96.

PMID: 33679049 PMC: 7897874. DOI: 10.1016/j.jceh.2020.08.003.


Severity of Anaemia Has Corresponding Effects on Coagulation Parameters of Sickle Cell Disease Patients.

Antwi-Baffour S, Kyeremeh R, Annison L Diseases. 2019; 7(4).

PMID: 31861183 PMC: 6956179. DOI: 10.3390/diseases7040059.


Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?.

Rozen L, Noubouossie D, Dedeken L, Le P, Ferster A, Demulder A J Clin Med. 2019; 8(11).

PMID: 31717804 PMC: 6912463. DOI: 10.3390/jcm8111796.